Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity

NCT02285374 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Dolutegravir, efavirenz, efavirenz/emtricitabine/tenofovir

Sponsor

St Stephens Aids Trust

Collaborators

[object Object]